Abstract
In the era of effective antiretroviral therapy (ART), HIV has transitioned from a terminal illness to a manageable chronic condition. However, clinical success is often narrowly defined by "immune restoration"—rising CD4+ T cell counts and undetectable viral loads—while the psychological well-being of patients remains overlooked. This cross-sectional study of 4,103 HIV-infected adults across China investigates the prevalence and risk factors of anxiety and depression, highlighting a significant "double burden" of mental health that persists despite biological stability.
Introduction
As HIV care in China evolves, there is an increasing recognition that physical health markers do not tell the whole story. While ART successfully suppresses viral replication, patients often face a secondary epidemic of mental health challenges. In many Chinese clinical settings, psychiatric screening is not yet routine, leaving anxiety and depression largely unrecognized. This study aims to quantify these disorders among physically stable patients and identify the psychosocial and clinical factors that drive them.
Methods
The researchers conducted a large-scale cross-sectional study involving 4,103 HIV-infected adults across 20 treatment clinics in 14 Chinese provinces between September 2014 and November 2015. Mental health was assessed using a two-pronged approach:
- Standardized Screening: The Hospital Anxiety and Depression (HAD) scale was used, with a score of $\ge 8$ on subscales (HAD-A for anxiety, HAD-D for depression) indicating high risk.
- Clinician Assessment: Doctors asked patients a single-item question regarding their experience of anxiety or depression in the prior month.
- Sleep Quality: The Pittsburgh Sleep Quality Index (PSQI) measured sleep disturbance.
Multivariable logistic regression was then employed to determine the statistical associations between socio-demographic, psychosocial, and clinical variables and mental health outcomes.
Results
Prevalence and the Screening Gap
The study found a high prevalence of mental health symptoms: 32.9% of the cohort met the criteria for depression, 27.4% for anxiety, and 19.0% suffered from both. A critical finding was the massive discrepancy between standardized screening and informal clinician inquiries.
As shown in the data, over 53% of patients who scored as "depressed" on the HAD-D scale did not report feeling depressed when asked a simple "yes/no" question by their doctor. This highlights a significant failure of ad-hoc screening to identify at-risk patients in a clinical setting.
Risk Factors and Biological Decoupling
Perhaps the most significant insight is the "biological decoupling" of mental health from HIV disease status. Multivariable analysis revealed that HIV-specific clinical markers, such as current CD4+ T cell count and viral load, were not significantly associated with anxiety or depression.
Instead, mental health outcomes were driven by psychosocial factors. Risk factors for depression included older age, lower educational attainment, unemployment, and lack of support from family or friends. Anxiety was significantly associated with the recentness of an HIV diagnosis and sleep disturbance. Notably, sleep disturbance emerged as one of the strongest predictors for both conditions (Adjusted Odds Ratio of 3.21 for depression and 4.10 for anxiety).
Discussion
The findings suggest that once a patient achieves immune restoration through ART, their mental health is governed more by their social and psychological environment than by the virus itself. The high prevalence of these disorders, combined with the inadequacy of informal clinician screening, underscores the need for integrating standardized tools like the HAD scale into routine HIV care in China.
Limitations and Future Directions
As a cross-sectional study, this research cannot establish causality—for instance, whether sleep disturbance causes depression or vice versa. Furthermore, the reliance on self-reporting may be influenced by cultural stigmas surrounding mental health. Future work should focus on longitudinal studies and the implementation of targeted interventions, such as sleep hygiene improvements and psychological support for newly diagnosed patients, to address this hidden epidemic.
Summary updated